1. Home
  2. FOUR vs BPMC Comparison

FOUR vs BPMC Comparison

Compare FOUR & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOUR
  • BPMC
  • Stock Information
  • Founded
  • FOUR 1999
  • BPMC 2008
  • Country
  • FOUR United States
  • BPMC United States
  • Employees
  • FOUR N/A
  • BPMC N/A
  • Industry
  • FOUR Business Services
  • BPMC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOUR Consumer Discretionary
  • BPMC Health Care
  • Exchange
  • FOUR Nasdaq
  • BPMC Nasdaq
  • Market Cap
  • FOUR 6.3B
  • BPMC 5.8B
  • IPO Year
  • FOUR 2020
  • BPMC 2015
  • Fundamental
  • Price
  • FOUR $97.76
  • BPMC $128.34
  • Analyst Decision
  • FOUR Buy
  • BPMC Buy
  • Analyst Count
  • FOUR 21
  • BPMC 20
  • Target Price
  • FOUR $113.37
  • BPMC $127.82
  • AVG Volume (30 Days)
  • FOUR 1.2M
  • BPMC 4.8M
  • Earning Date
  • FOUR 08-07-2025
  • BPMC 07-31-2025
  • Dividend Yield
  • FOUR N/A
  • BPMC N/A
  • EPS Growth
  • FOUR 99.89
  • BPMC N/A
  • EPS
  • FOUR 2.82
  • BPMC N/A
  • Revenue
  • FOUR $3,471,500,000.00
  • BPMC $562,121,000.00
  • Revenue This Year
  • FOUR $23.49
  • BPMC $44.46
  • Revenue Next Year
  • FOUR $20.98
  • BPMC $32.78
  • P/E Ratio
  • FOUR $34.65
  • BPMC N/A
  • Revenue Growth
  • FOUR 27.39
  • BPMC 99.19
  • 52 Week Low
  • FOUR $57.45
  • BPMC $73.04
  • 52 Week High
  • FOUR $127.50
  • BPMC $128.50
  • Technical
  • Relative Strength Index (RSI)
  • FOUR 61.56
  • BPMC 75.07
  • Support Level
  • FOUR $91.07
  • BPMC $128.06
  • Resistance Level
  • FOUR $100.53
  • BPMC $128.45
  • Average True Range (ATR)
  • FOUR 2.74
  • BPMC 0.30
  • MACD
  • FOUR 0.31
  • BPMC -1.16
  • Stochastic Oscillator
  • FOUR 78.01
  • BPMC 73.91

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

Share on Social Networks: